Clinical Trial Update: Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether losartan can reduce radiation-induced fibrosis in breast cancer patients. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiation-induced Fibrosis

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: Shaw Cancer Center | Conditions: Radiation Induced Fibrosis | Phase 2 | Status: RECRUITING